date:Feb 25, 2019
k at the full force of our inspectional resources, the FDA is maintaining global vigilance by concentrating inspections on higher risk facilities. As global compliance trends change and standards in some sectors improve we should expect to see an evolution in these trends.
FACT: FDA takes strong compliance and enforcement action when issues are observed
While the numbers of inspections have varied over the past few years, compliance actions, including warning letters, have increased. Warning